The main drafting unit of the "Twelfth Five-Year" development plan for the pharmaceutical industry——Relevant persons from the Pharmaceutical Division of the Consumer Goods Industry Department of the Ministry of Industry and Information Technology made a special trip to the China Pharmaceutical Packaging Association to solicit opinions on the drafting of the "Twelfth Five-Year Plan" development plan for the pharmaceutical industry and listen to it at the same time Packaging Association's "Twelfth Five-Year Plan" report on planning work. At the meeting, the Pharmaceutical Packaging Association called for pharmaceutical packaging to be placed on the same status as drugs.

Relevant persons from the Ministry of Industry and Information Technology and the Ministry of Science and Technology introduced the preparation of the pharmaceutical industry's "Twelfth Five-Year Plan" and the "Twelfth Five-Year Plan" technology plan for the pharmaceutical industry and their suggestions at the meeting. Cai Hong, Secretary General of China Pharmaceutical Packaging Association Reported on the status quo of the development of the pharmaceutical packaging industry and suggestions on the “Twelfth Five-Year Plan”. According to her, as of this year, the total output value of the pharmaceutical packaging industry has reached 35 billion yuan, with 1,500 enterprises. Cai Hong said that during the "Eleventh Five-Year Plan" period, the proportion of the pharmaceutical packaging industry in the total output value of the pharmaceutical industry has shown a downward trend. At present, the output value of the pharmaceutical packaging material industry accounts for less than 10% of the total output value of the pharmaceutical industry, which is much lower than that of developed countries. % Around the level. At the same time, the pharmaceutical packaging industry has low profits, insufficient research and development capabilities, and all high-end technologies, products and equipment rely on imports. She believes that pharmaceutical packaging is an important part of the pharmaceutical industry. Packaging materials and containers that directly contact drugs are the basic elements of drugs and have an important impact on drug quality and drug safety. She urged that in the "Twelfth Five-Year Plan" for the pharmaceutical industry, pharmaceutical packaging should be placed in the same position as pharmaceuticals and developed simultaneously with pharmaceutical preparations. Policy support for the pharmaceutical packaging industry should be increased.

Zhang Heyong, Honorary President of the China Pharmaceutical Packaging Association, said that my country is now implementing a new version of GMP to improve the quality of medicines. Pharmaceutical packaging must keep pace with the times, develop high-end products and meet the new requirements of the pharmaceutical industry. If there is no upgrade of the pharmaceutical packaging material industry, the pharmaceutical standards should be improved. And quality efforts will not be achieved.

The head of the Department of Biotechnology and Medicine of the Department of Social Development, Science and Technology of the Ministry of Science and Technology, relevant leaders of the China Pharmaceutical Packaging Association, experts from some pharmaceutical packaging material quality inspection institutions, pharmaceutical packaging companies and pharmaceutical manufacturers participated in the forum.

Welcome to Yangzhou Jerelpack Pharmaceutical New Material Co., Ltd.: www.jerelpack.com